Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1900 of 2873 entries
View as:

Non Invasive Oral Cancer Screening Among HIV Infected Individuals

Phase: N/A Priority: Normal
NCT ID: NCT02823847 Org: User:
Start: 06/30/16 End: 07/26/21 Due: 07/26/22

Difference in the Estimation of Prognosis

Phase: N/A Priority: Normal
NCT ID: NCT03115528 Org: User:
Start: 12/14/17 End: 12/31/30 Due: 12/31/31

Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx

Phase: N/A Priority: Normal
NCT ID: NCT00004246 Org: User:
Start: 06/07/95 End: 12/02/02 Due: 12/02/03

Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT00493454 Org: User:
Start: 04/30/06 End: 03/31/11 Due: 03/31/12

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03911388 Org: User:
Start: 09/12/19 End: 09/01/27 Due: 09/01/28

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Phase: N/A Priority: Normal
NCT ID: NCT02276443 Org: User:
Start: 11/09/15 End: 11/30/26 Due: 11/30/27

OraTest in Combination With Visual Examination and Visual Examination Alone

Phase: N/A Priority: Normal
NCT ID: NCT00537199 Org: User:
Start: 11/30/06 End: 12/31/08 Due: 12/31/09

New Assessment System in Measuring Symptom Distress in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00505245 Org: User:
Start: 04/13/99 End: 04/30/31 Due: 04/30/32

Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04189757 Org: User:
Start: 08/07/20 End: 06/30/27 Due: 06/30/28

Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05041101 Org: User:
Start: 12/21/21 End: 09/06/24 Due: 09/06/25

Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease

Phase: N/A Priority: Normal
NCT ID: NCT03441061 Org: User:
Start: 02/15/18 End: 02/28/27 Due: 02/28/28

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06053658 Org: User:
Start: 01/05/24 End: 11/01/28 Due: 11/01/29

Relaxation for Women With Breast Cancer Undergoing Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01202851 Org: User:
Start: 02/10/11 End: 02/28/26 Due: 02/28/27

Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy

Phase: N/A Priority: Normal
NCT ID: NCT00508703 Org: User:
Start: 03/05/03 End: 09/08/17 Due: 09/08/18

Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)

Phase: N/A Priority: Normal
NCT ID: NCT00364286 Org: User:
Start: 08/31/06 End: 11/30/12 Due: 11/30/13

Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00086762 Org: User:
Start: 06/30/04 End: 08/11/22 Due: 08/11/23

Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study

Phase: N/A Priority: Normal
NCT ID: NCT01024166 Org: User:
Start: 11/30/09 End: 06/30/12 Due: 06/30/13

Lenvatinib and Capecitabine in Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02915172 Org: User:
Start: 12/31/16 End: - Due: -

Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.

Phase: N/A Priority: Normal
NCT ID: NCT01173692 Org: User:
Start: 07/22/10 End: 07/07/20 Due: 07/07/21

Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01636609 Org: User:
Start: 11/20/12 End: 07/04/19 Due: 07/04/20

Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT03407001 Org: User:
Start: 01/12/18 End: 09/15/20 Due: 09/15/21

Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway

Phase: N/A Priority: Normal
NCT ID: NCT02740114 Org: User:
Start: 08/31/16 End: 07/23/20 Due: 07/23/21

Project Self in Improving Cervical Cancer Screening Rates in Hispanic and African American Women

Phase: N/A Priority: Normal
NCT ID: NCT04614155 Org: User:
Start: 08/27/19 End: 01/01/26 Due: 01/01/27

CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00270907 Org: User:
Start: 12/31/05 End: 10/31/12 Due: 10/31/13

Temsirolimus in Combination With Metformin in Patients With Advanced Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01529593 Org: User:
Start: 03/26/12 End: 03/14/25 Due: 03/14/26